XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 30,971,000 $ 31,800,000 $ 37,466,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, amortization and impairment 5,899,000 5,277,000 6,374,000
Reclassification of cumulative translation adjustment into earnings (0) 2,569,000 (0)
Deferred income taxes (1,121,000) (1,729,000) (277,000)
Reserve for uncertain tax positions 404,000 488,000 310,000
Loss on disposal of property and equipment 0 11,000 7,000
Non-cash share-based compensation expense 935,000 1,200,000 623,000
Change in assets and liabilities:      
Trade accounts receivable 2,084,000 (733,000) 343,000
Prepaid expenses and other current and long-term assets (1,767,000) 1,634,000 (842,000)
Operating lease assets and liability, net (127,000) (39,000) (34,000)
Deferred contract costs, net 988,000 1,331,000 783,000
Accounts payable 184,000 (589,000) 4,000
Accrued expenses, wages and bonuses (768,000) (2,947,000) (285,000)
Income taxes receivable and payable 795,000 6,000 484,000
Deferred revenue (364,000) (2,014,000) 1,388,000
Net cash provided by operating activities 38,113,000 36,265,000 46,344,000
Cash flows from investing activities:      
Purchases of property and equipment (15,779,000) (9,835,000) (5,514,000)
Acquisition consideration 0 0 (3,000,000)
Proceeds from the sale of property and equipment 1,000 0 0
Net cash used in investing activities (15,778,000) (9,835,000) (8,514,000)
Cash flows from financing activities:      
Payments on notes payable (4,528,000) (4,305,000) (4,093,000)
Payment of debt issuance costs (8,000) (92,000) 0
Borrowings on notes payable 19,000,000 0 0
Borrowings on line of credit 15,000,000 0 0
Payments on line of credit (15,000,000) 0 0
Payments on finance lease obligations (290,000) (469,000) (493,000)
Proceeds from the exercise of stock options 584,000 0 446,000
Payment of payroll tax withholdings on share-based awards exercised 0 (190,000) (721,000)
Payment of deferred acquisition consideration 0 (1,950,000) 0
Repurchase of shares for treasury (19,099,000) (27,616,000) (4,142,000)
Payment of dividends on common stock (36,366,000) (20,961,000) (9,159,000)
Net cash used in financing activities (40,707,000) (55,583,000) (18,162,000)
Effect of exchange rate changes on cash (1,000) (182,000) 3,000
Net increase (decrease) in cash and cash equivalents (18,373,000) (29,335,000) 19,671,000
Cash and cash equivalents at beginning of period 25,026,000 54,361,000 34,690,000
Cash and cash equivalents at end of period 6,653,000 25,026,000 54,361,000
Supplemental disclosure of cash paid for:      
Interest expense, net of capitalized amounts 803,000 1,227,000 1,684,000
Income taxes 8,932,000 12,233,000 10,644,000
Supplemental disclosure of non-cash investing and financing activities:      
Finance lease obligations originated for property and equipment 0 0 40,000
Purchase of property and equipment in accounts payable and accrued expenses 2,066,000 1,109,000 979,000
Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans 1,241,000 311,000 1,088,000
Repurchase of shares for treasury in accounts payable and accrued expenses 152,000 0 0
Deferred acquisition consideration $ 0 $ 0 $ 1,950,000